Clairfield advises Holland on the sale of Mauritskliniek to Corius
Holland Capital, a Dutch private equity firm, sold Mauritskliniek to Corius, a portfolio company of Swiss-based Ufenau Capital Partners.
Mauritskliniek is a specialised clinic for dermatology, the treatment of varicose veins, and medical-cosmetic care. After the acquisition of Kliniek Veldhoven in 2020, the company expanded its range of cosmetic care treatments. The clinics are known for their high level of quality offerings and patient attention and boast high patient satisfaction rates, according to web-rating sites. The clinics offer insured and uninsured care.
Corius is a network of dermatology and phlebology practices. Doctors and partners of Corius deliver the highest level of service and use the most cutting-edge technology. Corius offers its patients holistic and individual treatments, and their in-house expert knowledge is shared across their clinics and colleagues. Employees undertake additional education and training throughout their careers. Corius has 32 practices and 615 employees, and it employs 139 doctors and treats approximately 450,000 patients annually.
Healthcare

Advisor to the seller
Services :
Mergers & acquisitions
Sectors :
Healthcare
Countries involved :
Germany
Netherlands
Switzerland
Deal team :